cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5281/zenodo.18534949
title: UTERINE FIBROIDS (LEIOMYOMA): ETIOLOGY, CLINICAL MANIFESTATIONS, AND MODERN TREATMENT APPROACHES

description: Uterine fibroids, also known as leiomyomas, are the most common benign tumors of the female reproductive system, originating from the smooth muscle cells of the myometrium. They affect up to 60–70% of women of reproductive age, with higher prevalence observed among women aged 30–50 years. Although many fibroids remain asymptomatic, a significant proportion cause clinical symptoms that negatively impact quality of life and reproductive health. The exact etiology of uterine fibroids is multifactorial and not fully understood; however, hormonal influences, genetic predisposition, growth factors, and environmental factors play crucial roles in their development and progression.

Clinically, uterine fibroids present with a wide spectrum of symptoms, including abnormal uterine bleeding, pelvic pain, pressure symptoms on adjacent organs, infertility, and pregnancy complications. Diagnosis is primarily based on pelvic examination and imaging modalities, particularly transvaginal ultrasonography and magnetic resonance imaging.

Management of uterine fibroids has evolved significantly over recent decades. Traditional surgical treatments such as myomectomy and hysterectomy remain definitive options, especially in severe cases. However, modern medical therapies, minimally invasive procedures, and uterus-sparing techniques have expanded treatment choices, allowing individualized management based on patient age, symptom severity, fertility desires, and fibroid characteristics. These include hormonal therapies, gonadotropin-releasing hormone (GnRH) analogs and antagonists, selective progesterone receptor modulators, uterine artery embolization, and focused ultrasound surgery.

This article provides a comprehensive overview of the etiology, pathophysiology, clinical manifestations, diagnostic approaches, and contemporary treatment strategies for uterine fibroids. Emphasis is placed on evidence-based management and personalized treatment planning to optimize clinical outcomes and preserve reproductive potential when desired.
DOI: 10.15468/dl.nnm48v
title: Occurrence Download

description: A dataset containing 464674 records in GBIF matching the query:

 SELECT gbifid, datasetkey, specieskey, kingdom, phylum, class, "order", family, genus, species, scientificname, decimallatitude, decimallongitude, eventdate, institutioncode, "year" AS obs_year, basisofrecord, coordinateuncertaintyinmeters, issue
 FROM occurrence
 WHERE
 decimallatitude IS NOT NULL
 AND decimallongitude IS NOT NULL
 AND NOT ARRAY_CONTAINS(issue, 'ZERO_COORDINATE')
 AND NOT ARRAY_CONTAINS(issue, 'COORDINATE_OUT_OF_RANGE')
 AND NOT ARRAY_CONTAINS(issue, 'COORDINATE_INVALID')
 AND NOT ARRAY_CONTAINS(issue, 'COUNTRY_COORDINATE_MISMATCH')
 AND "year" &gt;= 2015
 AND "year" &lt;= 2026
 AND coordinateuncertaintyinmeters IS NOT NULL
 AND coordinateuncertaintyinmeters &gt; 0
 AND coordinateuncertaintyinmeters &lt;= 200.0
 AND decimallatitude &gt;= 41.89415215079384
 AND decimallatitude &lt;= 46.479780028101516
 AND decimallongitude &gt;= -119.59356374412798
 AND decimallongitude &lt;= -107.89334554252557
 AND GBIF_Within('POLYGON ((-107.893346 41.894152, -107.893346 46.479780, -119.593564 46.479780, -119.593564 41.894152, -107.893346 41.894152))', decimallatitude, decimallongitude) = TRUE
 

 The dataset's 464674 records were derived from 102 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002091-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.18515233
title: Multi-modal characterization of nitrate reduction nano-catalysts with periodic strain distribution

description: This dataset contains the processed results derived from 4D-STEM measurements, including spatially resolved strain mapping and the corresponding adsorption energy distributions. Files related to strain mapping (e.g., CoSn_Strain.mat, CuCoSn_Strain.mat, Fig2a_Strainmapping.m) provide the real-space strain fields extracted from 4D-STEM diffraction datasets, together with analyses of strain periodicity (MEOH_StrainPeriod.mat) and EDS-derived elemental periodicity (EDS_Period.mat, EDS_Ratio.mat), which characterize the coupled structural and compositional modulation at the nanoscale. Files such as ActivationEnergy.mat, ActivationEnergy1.mat, and Period_AE.mat, etc., present the calculated adsorption energy maps and their associated statistical or periodic analyses.
DOI: 10.5281/zenodo.18515234
title: Multi-modal characterization of nitrate reduction nano-catalysts with periodic strain distribution

description: This dataset contains the processed results derived from 4D-STEM measurements, including spatially resolved strain mapping and the corresponding adsorption energy distributions. Files related to strain mapping (e.g., CoSn_Strain.mat, CuCoSn_Strain.mat, Fig2a_Strainmapping.m) provide the real-space strain fields extracted from 4D-STEM diffraction datasets, together with analyses of strain periodicity (MEOH_StrainPeriod.mat) and EDS-derived elemental periodicity (EDS_Period.mat, EDS_Ratio.mat), which characterize the coupled structural and compositional modulation at the nanoscale. Files such as ActivationEnergy.mat, ActivationEnergy1.mat, and Period_AE.mat, etc., present the calculated adsorption energy maps and their associated statistical or periodic analyses.
DOI: 10.15468/dl.rzjvzs
title: Occurrence Download

description: A dataset containing 154 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Gastrotheca argenteovirens"
 ]
}

 The dataset includes 154 records from 16 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002093-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.18535048
title: "TEMUR TRAPS" THROUGH THE EYES OF WORLD HISTORIANS

description: This article describes the biography of Amir Temur, his socio-political activity, his seizure of central power in Movarounnahir, the elimination of political fragmentation, the formation of a centralized state, the inclusion of 27 countries in his classification. It discusses who to trust in the administration of the state, the attitude and duties of the holders of the crown, the choice of ministers and commanders of the army, the structure of the army and the rules of warfare, the salaries of soldiers, the order of governing the country, the duties and duties of statesmen and commanders of the army, the way of rewarding the special services rendered by superiors, ministers and other officials before the crown and much more.
DOI: 10.5281/zenodo.18535047
title: "TEMUR TRAPS" THROUGH THE EYES OF WORLD HISTORIANS

description: This article describes the biography of Amir Temur, his socio-political activity, his seizure of central power in Movarounnahir, the elimination of political fragmentation, the formation of a centralized state, the inclusion of 27 countries in his classification. It discusses who to trust in the administration of the state, the attitude and duties of the holders of the crown, the choice of ministers and commanders of the army, the structure of the army and the rules of warfare, the salaries of soldiers, the order of governing the country, the duties and duties of statesmen and commanders of the army, the way of rewarding the special services rendered by superiors, ministers and other officials before the crown and much more.
DOI: 10.15468/dl.hwwqj4
title: Occurrence Download

description: A dataset containing 207973 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Morone",
 "HasCoordinate is true",
 "HasGeospatialIssue is false"
 ]
}

 The dataset includes 207973 records from 113 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002084-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.34740/kaggle/dsv/14780482
title: Peer-to-Peer Boliviano (BOB) Exchange Data
DOI: 10.15468/dl.utrh4d
title: Occurrence Download

description: A dataset containing 2418 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Nasalis larvatus"
 ]
}

 The dataset includes 2418 records from 55 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002096-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.18535174
title: THE ROLE OF THE IMMUNE SYSTEM IN THE DEVELOPMENT OF ACUTE RESPIRATORY VIRAL INFECTIONS IN CHILDREN

description: Acute Respiratory Viral Infections (ARVI) are among the most common infectious diseases affecting children worldwide and represent a major cause of morbidity, healthcare utilization, and school absenteeism. The susceptibility of children to ARVI is closely linked to the developmental characteristics of their immune system. Unlike adults, children possess an immature immune response that undergoes gradual maturation through early childhood, influencing both the frequency and severity of viral respiratory infections. This article explores the role of the immune system in the pathogenesis and progression of ARVI in pediatric populations. It examines the interaction between innate and adaptive immune responses, the influence of age-related immunological development, and the impact of environmental and genetic factors on immune competence. A comprehensive review of existing literature highlights how deficiencies in mucosal immunity, reduced interferon production, and limited immunological memory contribute to increased vulnerability in children. Furthermore, this paper discusses the implications of immune dysregulation, including hyperinflammatory responses and secondary bacterial infections. Understanding immune mechanisms involved in ARVI development provides a foundation for improving preventive strategies, optimizing immunomodulatory therapies, and reducing disease burden. The findings emphasize the importance of early immune system support through vaccination, nutrition, and environmental control. This article contributes to pediatric infectious disease research by integrating immunological theory with clinical observations, offering a holistic perspective on ARVI development in children.
DOI: 10.5281/zenodo.18535175
title: THE ROLE OF THE IMMUNE SYSTEM IN THE DEVELOPMENT OF ACUTE RESPIRATORY VIRAL INFECTIONS IN CHILDREN

description: Acute Respiratory Viral Infections (ARVI) are among the most common infectious diseases affecting children worldwide and represent a major cause of morbidity, healthcare utilization, and school absenteeism. The susceptibility of children to ARVI is closely linked to the developmental characteristics of their immune system. Unlike adults, children possess an immature immune response that undergoes gradual maturation through early childhood, influencing both the frequency and severity of viral respiratory infections. This article explores the role of the immune system in the pathogenesis and progression of ARVI in pediatric populations. It examines the interaction between innate and adaptive immune responses, the influence of age-related immunological development, and the impact of environmental and genetic factors on immune competence. A comprehensive review of existing literature highlights how deficiencies in mucosal immunity, reduced interferon production, and limited immunological memory contribute to increased vulnerability in children. Furthermore, this paper discusses the implications of immune dysregulation, including hyperinflammatory responses and secondary bacterial infections. Understanding immune mechanisms involved in ARVI development provides a foundation for improving preventive strategies, optimizing immunomodulatory therapies, and reducing disease burden. The findings emphasize the importance of early immune system support through vaccination, nutrition, and environmental control. This article contributes to pediatric infectious disease research by integrating immunological theory with clinical observations, offering a holistic perspective on ARVI development in children.
DOI: 10.15468/dl.dqge9x
title: Occurrence Download

description: A dataset containing 2 species occurrences available in GBIF matching the query:
{
 "and" : [
 "OccurrenceStatus is Present",
 "TaxonKey is Bothrops ayerbei"
 ]
}

 The dataset includes 2 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002097-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.31291849
title: Supplementary Material for: Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial

description: Introduction: Patients with advanced stages of chronic kidney disease (CKD) and dialysis-dependent kidney failure are at a greater risk of cardiovascular events and mortality than those with early stages of CKD. There are no completed definitive randomized trials on the safety and efficacy of anticoagulant therapy in this patient population. 
Methods: Treatment of cardiovascular disease with low-dose Rivaroxaban in Advanced Chronic Kidney disease (TRACK) is a multi-center, randomized, placebo-controlled trial (NCT03969953), designed to enrol 1886 adult participants with CKD stage 4 or 5 (estimated glomerular filtration rate 29 mL/min/1.73 m2) or dialysis-dependent kidney failure and high cardiovascular risk (defined as at least one of the following risk factors; coronary artery disease, non-hemorrhagic non-lacunar stroke, peripheral artery disease [PAD], diabetes mellitus, or age 65 years). Participants are randomized to rivaroxaban 2.5 mg twice daily or matching placebo. The primary efficacy outcome is a composite of cardiovascular death, myocardial infarction, stroke, or PAD event. The primary safety outcome is major bleeding, defined as a composite of fatal bleeding, bleeding leading to hospitalization, or symptomatic bleeding in a critical area or organ. From January 2021 through July 2025, 1458 eligible participants (mean age 63.2 years, 700 [48%] age 65 years, 432 [29.6%] women, 715 [49%] dialysis-dependent kidney failure and 743 [51%] CKD stage 4 or 5, 1125 [77.2%] diabetes mellitus, 674 [46.2%] treated with aspirin at baseline) underwent randomization. 
Conclusion: TRACK will evaluate the effect of low dose rivaroxaban on major adverse cardiovascular events in participants with CKD stages 4 and 5 and dialysis-dependent kidney failure, and elevated cardiovascular risk.
DOI: 10.6084/m9.figshare.31291849.v1
title: Supplementary Material for: Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial

description: Introduction: Patients with advanced stages of chronic kidney disease (CKD) and dialysis-dependent kidney failure are at a greater risk of cardiovascular events and mortality than those with early stages of CKD. There are no completed definitive randomized trials on the safety and efficacy of anticoagulant therapy in this patient population. 
Methods: Treatment of cardiovascular disease with low-dose Rivaroxaban in Advanced Chronic Kidney disease (TRACK) is a multi-center, randomized, placebo-controlled trial (NCT03969953), designed to enrol 1886 adult participants with CKD stage 4 or 5 (estimated glomerular filtration rate 29 mL/min/1.73 m2) or dialysis-dependent kidney failure and high cardiovascular risk (defined as at least one of the following risk factors; coronary artery disease, non-hemorrhagic non-lacunar stroke, peripheral artery disease [PAD], diabetes mellitus, or age 65 years). Participants are randomized to rivaroxaban 2.5 mg twice daily or matching placebo. The primary efficacy outcome is a composite of cardiovascular death, myocardial infarction, stroke, or PAD event. The primary safety outcome is major bleeding, defined as a composite of fatal bleeding, bleeding leading to hospitalization, or symptomatic bleeding in a critical area or organ. From January 2021 through July 2025, 1458 eligible participants (mean age 63.2 years, 700 [48%] age 65 years, 432 [29.6%] women, 715 [49%] dialysis-dependent kidney failure and 743 [51%] CKD stage 4 or 5, 1125 [77.2%] diabetes mellitus, 674 [46.2%] treated with aspirin at baseline) underwent randomization. 
Conclusion: TRACK will evaluate the effect of low dose rivaroxaban on major adverse cardiovascular events in participants with CKD stages 4 and 5 and dialysis-dependent kidney failure, and elevated cardiovascular risk.
DOI: 10.6084/m9.figshare.31291852
title: Supplementary Material for: Hemoglobin-to-Red Cell Distribution Width Ratio at Admission as an Anemia-Independent Predictor of Mortality after Fragility Hip Fracture Surgery in Older Adults

description: Background: The hemoglobin-to-red cell distribution width ratio (HRR), which has demonstrated better predictive ability than the red blood cell distribution width (RDW) and hemoglobin (Hb) level, has not been used to predict orthopedic surgical outcomes and may be a novel prognostic parameter for mortality.
Methods: In this single-center cohort study, data of 363 patients (aged ≥60 years) who underwent surgery for fragility hip fracture at our institution between January 2016 and December 2018 were retrospectively analyzed. Multivariable Cox proportional hazards and Kaplan–Meier survival curve analyses were performed to compare the high and low HRR and RDW groups, divided based on cutoff values. The power of mortality prediction over time was assessed by comparing Harrell’s concordance index using the bootstrapping method.
Results: Among 363 patients, the overall mortality was 48.48% (176/363), with a mean±standard deviation of 4.31±2.09 (0.02–7.44) years. HRR was significantly associated with all-cause mortality after hip fracture surgery (hazard ratio: 0.989; 95% confidence interval: 0.978–0.999; p=0.044). Moreover, during the follow-up period after 1 year, HRR demonstrated the second-highest predictive ability for mortality among all laboratory parameters and indicators reflecting general condition, and it remained unaffected by anemia status for up to 4 years.
Conclusions: HRR is proposed as a novel prognostic indicator for mid- to long-term survival after hip fracture surgery in older patients.
DOI: 10.6084/m9.figshare.31291852.v1
title: Supplementary Material for: Hemoglobin-to-Red Cell Distribution Width Ratio at Admission as an Anemia-Independent Predictor of Mortality after Fragility Hip Fracture Surgery in Older Adults

description: Background: The hemoglobin-to-red cell distribution width ratio (HRR), which has demonstrated better predictive ability than the red blood cell distribution width (RDW) and hemoglobin (Hb) level, has not been used to predict orthopedic surgical outcomes and may be a novel prognostic parameter for mortality.
Methods: In this single-center cohort study, data of 363 patients (aged ≥60 years) who underwent surgery for fragility hip fracture at our institution between January 2016 and December 2018 were retrospectively analyzed. Multivariable Cox proportional hazards and Kaplan–Meier survival curve analyses were performed to compare the high and low HRR and RDW groups, divided based on cutoff values. The power of mortality prediction over time was assessed by comparing Harrell’s concordance index using the bootstrapping method.
Results: Among 363 patients, the overall mortality was 48.48% (176/363), with a mean±standard deviation of 4.31±2.09 (0.02–7.44) years. HRR was significantly associated with all-cause mortality after hip fracture surgery (hazard ratio: 0.989; 95% confidence interval: 0.978–0.999; p=0.044). Moreover, during the follow-up period after 1 year, HRR demonstrated the second-highest predictive ability for mortality among all laboratory parameters and indicators reflecting general condition, and it remained unaffected by anemia status for up to 4 years.
Conclusions: HRR is proposed as a novel prognostic indicator for mid- to long-term survival after hip fracture surgery in older patients.
DOI: 10.5281/zenodo.18535057
title: Cognitive Event Density: Quantifying Sovereign Time Dilation and Institutional Latency

description: This paper introduces Cognitive Event Density (CED), a novel metric measuring the rate of

pattern-recognition events during high-cognitive states. Empirical measurements show

sovereign cognition operates at CED = 0.45 events/second, representing 22.5× temporal

dilation relative to baseline human cognition (0.02 events/second).
DOI: 10.5281/zenodo.18535058
title: Cognitive Event Density: Quantifying Sovereign Time Dilation and Institutional Latency

description: This paper introduces Cognitive Event Density (CED), a novel metric measuring the rate of

pattern-recognition events during high-cognitive states. Empirical measurements show

sovereign cognition operates at CED = 0.45 events/second, representing 22.5× temporal

dilation relative to baseline human cognition (0.02 events/second).
DOI: 10.5281/zenodo.18534686
title: ㄴㅇㄻㄴㅇ

description: ㄴㅇㄹㄴㄻㄴㅇ
DOI: 10.5281/zenodo.18535245
title: ANALYSIS OF CLINICAL AND LABORATORY INDICATORS OF MYOCARDITIS AND MYOPERICARDITIS IN PATIENTS WITH COVID-19.

description: In December 2019, a new respiratory infection caused by a previously unidentified strain of coronavirus, named SARS-CoV-2, was identified in China. This virus belongs to the Coronaviridae family, Nidovirales, and is characterized by a pleomorphic structure with crown-like spikes on its surface, which is why it was named "coronavirus". The size of the viral particles varies from 80 to 160 nanometers, and the genome length, expressed as positive-sense RNA, ranges from 27 to 32 kilobases. The emergence of SARS-CoV-2 led to a global pandemic, named COVID-19.
DOI: 10.5281/zenodo.18535246
title: ANALYSIS OF CLINICAL AND LABORATORY INDICATORS OF MYOCARDITIS AND MYOPERICARDITIS IN PATIENTS WITH COVID-19.

description: In December 2019, a new respiratory infection caused by a previously unidentified strain of coronavirus, named SARS-CoV-2, was identified in China. This virus belongs to the Coronaviridae family, Nidovirales, and is characterized by a pleomorphic structure with crown-like spikes on its surface, which is why it was named "coronavirus". The size of the viral particles varies from 80 to 160 nanometers, and the genome length, expressed as positive-sense RNA, ranges from 27 to 32 kilobases. The emergence of SARS-CoV-2 led to a global pandemic, named COVID-19.
DOI: 10.15468/dl.xcggmv
title: Occurrence Download

description: A dataset containing 13629 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Ranunculus aconitifolius, Ranunculus platanifolius)",
 "Year is greater than or equal to 1900",
 "Geometry POLYGON ((8.643 46.99, 14.1 46.92, 14.43 50.75, 8.534 50.83, 8.643 46.99))",
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 "BasisOfRecord is one of (Observation, Human Observation, Machine Observation, Material sample)"
 ]
}

 The dataset includes 13629 records from 24 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002098-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.